Abstract
There have been significant advances in the treatment of posttraumatic stress disorder in the last two decades. Further improvements in outcomes will be supported by recognition of the heterogeneity of symptoms in trauma populations and the development of treatments that promote the tailoring of interventions according to patient needs. Collaboration with patients regarding preferences about treatment structure, process, and outcomes is critical and will benefit the effectiveness and quality of treatments as well as the speed of their dissemination. New research methodologies are required that can incorporate important variables such as patient preferences and symptom heterogeneity without necessarily extending already lengthy study times or further complicating study designs. An example of alternative methodology is proposed.
This paper is part of the Special Issue: Trauma and PTSD: setting the research agenda. More papers from this issue can be found at www.ejpt.net
For the abstract or full text in other languages, please see Supplementary files under ‘Article Tools’
This paper is part of the Special Issue: Trauma and PTSD: setting the research agenda. More papers from this issue can be found at www.ejpt.net
For the abstract or full text in other languages, please see Supplementary files under ‘Article Tools’
Conflict of interest and funding
There is no conflict of interest in the present study for any of the authors.
Notes
This paper is part of the Special Issue: Trauma and PTSD: setting the research agenda. More papers from this issue can be found at www.ejpt.net
For the abstract or full text in other languages, please see Supplementary files under ‘Article Tools’